{"id":10538,"date":"2020-04-22T15:35:24","date_gmt":"2020-04-22T19:35:24","guid":{"rendered":"https:\/\/www.cosprc.ca\/?post_type=cos-resource&#038;p=10538"},"modified":"2021-06-21T23:23:34","modified_gmt":"2021-06-22T03:23:34","slug":"french-document-to-be-available-shortly","status":"publish","type":"post","link":"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/","title":{"rendered":"Recommandations suppl\u00e9mentaires pour la gestion du fardeau des injections d\u2019anti-VEGF pendant la pand\u00e9mie de COVID-19"},"content":{"rendered":"\n<figure class=\"wp-block-image is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/cosprc.ca\/wp-content\/uploads\/2020\/04\/image-9.png\" alt=\"This image has an empty alt attribute; its file name is image-9.png\" width=\"156\" height=\"52\"\/><\/figure>\n\n\n\n<p><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"164\" height=\"93\" src=\"https:\/\/cosprc.ca\/wp-content\/uploads\/2020\/04\/image-3.png\" alt=\"\" class=\"wp-image-9888\"\/><\/figure>\n\n\n\n<p>4&nbsp;avril&nbsp;2020<\/p>\n\n\n\n<p>Alors que\nle virus de la COVID-19 devient rapidement la grande crise de sant\u00e9 publique de\nnotre g\u00e9n\u00e9ration et que les cliniques externes r\u00e9duisent leurs horaires de\nconsultation dans l\u2019espoir de r\u00e9duire la transmission de la maladie aux\npersonnes vuln\u00e9rables, les ophtalmologistes doivent relever le d\u00e9fi de r\u00e9duire\nconsid\u00e9rablement l\u2019utilisation des m\u00e9dicaments anti-VEGF, m\u00eame si une pr\u00e9pond\u00e9rance\nde donn\u00e9es indique que pour de meilleurs r\u00e9sultats visuels, nous devons traiter\nles patients plus souvent que moins. <\/p>\n\n\n\n<p>Le probl\u00e8me est que l\u2019\u0153d\u00e8me maculaire diab\u00e9tique (OMD), la d\u00e9g\u00e9n\u00e9rescence maculaire n\u00e9ovasculaire li\u00e9e \u00e0 l\u2019\u00e2ge (DMLA) et l\u2019occlusion veineuse r\u00e9tinienne avec \u0153d\u00e8me maculaire cysto\u00efde (OVR-OMC) touchent des populations de patients plus \u00e2g\u00e9es, souvent atteints de comorbidit\u00e9s importantes \u2013 justement les personnes les plus susceptibles de n\u00e9cessiter une hospitalisation, d\u2019utiliser les ressources de l\u2019unit\u00e9 de soins intensifs ou de mourir si elles contractent la COVID-19. <\/p>\n\n\n\n<p> <strong>Details d\u2019acc\u00e8s<\/strong> <\/p>\n\n\n\n<p><a href=\"https:\/\/cosprc.ca\/wp-content\/uploads\/2020\/04\/Traduction-ACUPO-anti-VEGF_FR_20200422_v3.pdf\">Lisez la version int\u00e9grale des recommandations suppl\u00e9mentaires pour la gestion du fardeau des injections d\u2019anti-VEGF pendant la pand\u00e9mie de COVID-19<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4&nbsp;avril&nbsp;2020 Alors que le virus de la COVID-19 devient rapidement la grande crise de sant\u00e9 publique de notre g\u00e9n\u00e9ration et que les cliniques externes r\u00e9duisent leurs horaires de consultation dans l\u2019espoir de r\u00e9duire la transmission de la maladie aux personnes vuln\u00e9rables, les ophtalmologistes doivent relever le d\u00e9fi de r\u00e9duire consid\u00e9rablement l\u2019utilisation des m\u00e9dicaments anti-VEGF, m\u00eame [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[305,321],"post_tag":[],"content_type":[326],"class_list":["post-10538","post","type-post","status-publish","format-standard","hentry","category-pour-les-ophtalmologistes","category-ressources-de-la-covid-19","content_type-enonce-de-principes-et-lignes-directrices"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Recommandations suppl\u00e9mentaires pour la gestion du fardeau des injections d\u2019anti-VEGF pendant la pand\u00e9mie de COVID-19 - Practice Resource Centre<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Recommandations suppl\u00e9mentaires pour la gestion du fardeau des injections d\u2019anti-VEGF pendant la pand\u00e9mie de COVID-19 - Practice Resource Centre\" \/>\n<meta property=\"og:description\" content=\"4&nbsp;avril&nbsp;2020 Alors que le virus de la COVID-19 devient rapidement la grande crise de sant\u00e9 publique de notre g\u00e9n\u00e9ration et que les cliniques externes r\u00e9duisent leurs horaires de consultation dans l\u2019espoir de r\u00e9duire la transmission de la maladie aux personnes vuln\u00e9rables, les ophtalmologistes doivent relever le d\u00e9fi de r\u00e9duire consid\u00e9rablement l\u2019utilisation des m\u00e9dicaments anti-VEGF, m\u00eame [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/\" \/>\n<meta property=\"og:site_name\" content=\"Practice Resource Centre\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-22T19:35:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-22T03:23:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cosprc.ca\/wp-content\/uploads\/2020\/04\/image-9.png\" \/>\n<meta name=\"author\" content=\"Fetun Delessa\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fetun Delessa\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/french-document-to-be-available-shortly\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/french-document-to-be-available-shortly\\\/\"},\"author\":{\"name\":\"Fetun Delessa\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/#\\\/schema\\\/person\\\/3fca208dd4d156beb92f181ee1629eb1\"},\"headline\":\"Recommandations suppl\u00e9mentaires pour la gestion du fardeau des injections d\u2019anti-VEGF pendant la pand\u00e9mie de COVID-19\",\"datePublished\":\"2020-04-22T19:35:24+00:00\",\"dateModified\":\"2021-06-22T03:23:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/french-document-to-be-available-shortly\\\/\"},\"wordCount\":221,\"image\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/french-document-to-be-available-shortly\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cosprc.ca\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/image-9.png\",\"articleSection\":[\"Pour les ophtalmologistes\",\"Ressources sur la COVID-19\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/french-document-to-be-available-shortly\\\/\",\"url\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/french-document-to-be-available-shortly\\\/\",\"name\":\"Recommandations suppl\u00e9mentaires pour la gestion du fardeau des injections d\u2019anti-VEGF pendant la pand\u00e9mie de COVID-19 - Practice Resource Centre\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/french-document-to-be-available-shortly\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/french-document-to-be-available-shortly\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cosprc.ca\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/image-9.png\",\"datePublished\":\"2020-04-22T19:35:24+00:00\",\"dateModified\":\"2021-06-22T03:23:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/#\\\/schema\\\/person\\\/3fca208dd4d156beb92f181ee1629eb1\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/french-document-to-be-available-shortly\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/french-document-to-be-available-shortly\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/french-document-to-be-available-shortly\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cosprc.ca\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/image-9.png\",\"contentUrl\":\"https:\\\/\\\/cosprc.ca\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/image-9.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/french-document-to-be-available-shortly\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Recommandations suppl\u00e9mentaires pour la gestion du fardeau des injections d\u2019anti-VEGF pendant la pand\u00e9mie de COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/#website\",\"url\":\"https:\\\/\\\/www.cosprc.ca\\\/\",\"name\":\"Practice Resource Centre\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cosprc.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cosprc.ca\\\/#\\\/schema\\\/person\\\/3fca208dd4d156beb92f181ee1629eb1\",\"name\":\"Fetun Delessa\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a10a9c4e762ba75e5efa9baf63e485c514bcd87a33ad1c13fc83f941e4ef0034?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a10a9c4e762ba75e5efa9baf63e485c514bcd87a33ad1c13fc83f941e4ef0034?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a10a9c4e762ba75e5efa9baf63e485c514bcd87a33ad1c13fc83f941e4ef0034?s=96&d=mm&r=g\",\"caption\":\"Fetun Delessa\"},\"url\":\"https:\\\/\\\/www.cosprc.ca\\\/fr\\\/author\\\/rs9ebny670cpwyyn\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Recommandations suppl\u00e9mentaires pour la gestion du fardeau des injections d\u2019anti-VEGF pendant la pand\u00e9mie de COVID-19 - Practice Resource Centre","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/","og_locale":"fr_FR","og_type":"article","og_title":"Recommandations suppl\u00e9mentaires pour la gestion du fardeau des injections d\u2019anti-VEGF pendant la pand\u00e9mie de COVID-19 - Practice Resource Centre","og_description":"4&nbsp;avril&nbsp;2020 Alors que le virus de la COVID-19 devient rapidement la grande crise de sant\u00e9 publique de notre g\u00e9n\u00e9ration et que les cliniques externes r\u00e9duisent leurs horaires de consultation dans l\u2019espoir de r\u00e9duire la transmission de la maladie aux personnes vuln\u00e9rables, les ophtalmologistes doivent relever le d\u00e9fi de r\u00e9duire consid\u00e9rablement l\u2019utilisation des m\u00e9dicaments anti-VEGF, m\u00eame [&hellip;]","og_url":"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/","og_site_name":"Practice Resource Centre","article_published_time":"2020-04-22T19:35:24+00:00","article_modified_time":"2021-06-22T03:23:34+00:00","og_image":[{"url":"https:\/\/cosprc.ca\/wp-content\/uploads\/2020\/04\/image-9.png","type":"","width":"","height":""}],"author":"Fetun Delessa","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Fetun Delessa","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/#article","isPartOf":{"@id":"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/"},"author":{"name":"Fetun Delessa","@id":"https:\/\/www.cosprc.ca\/#\/schema\/person\/3fca208dd4d156beb92f181ee1629eb1"},"headline":"Recommandations suppl\u00e9mentaires pour la gestion du fardeau des injections d\u2019anti-VEGF pendant la pand\u00e9mie de COVID-19","datePublished":"2020-04-22T19:35:24+00:00","dateModified":"2021-06-22T03:23:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/"},"wordCount":221,"image":{"@id":"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/#primaryimage"},"thumbnailUrl":"https:\/\/cosprc.ca\/wp-content\/uploads\/2020\/04\/image-9.png","articleSection":["Pour les ophtalmologistes","Ressources sur la COVID-19"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/","url":"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/","name":"Recommandations suppl\u00e9mentaires pour la gestion du fardeau des injections d\u2019anti-VEGF pendant la pand\u00e9mie de COVID-19 - Practice Resource Centre","isPartOf":{"@id":"https:\/\/www.cosprc.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/#primaryimage"},"image":{"@id":"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/#primaryimage"},"thumbnailUrl":"https:\/\/cosprc.ca\/wp-content\/uploads\/2020\/04\/image-9.png","datePublished":"2020-04-22T19:35:24+00:00","dateModified":"2021-06-22T03:23:34+00:00","author":{"@id":"https:\/\/www.cosprc.ca\/#\/schema\/person\/3fca208dd4d156beb92f181ee1629eb1"},"breadcrumb":{"@id":"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/#primaryimage","url":"https:\/\/cosprc.ca\/wp-content\/uploads\/2020\/04\/image-9.png","contentUrl":"https:\/\/cosprc.ca\/wp-content\/uploads\/2020\/04\/image-9.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cosprc.ca\/fr\/french-document-to-be-available-shortly\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cosprc.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Recommandations suppl\u00e9mentaires pour la gestion du fardeau des injections d\u2019anti-VEGF pendant la pand\u00e9mie de COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/www.cosprc.ca\/#website","url":"https:\/\/www.cosprc.ca\/","name":"Practice Resource Centre","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cosprc.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.cosprc.ca\/#\/schema\/person\/3fca208dd4d156beb92f181ee1629eb1","name":"Fetun Delessa","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a10a9c4e762ba75e5efa9baf63e485c514bcd87a33ad1c13fc83f941e4ef0034?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a10a9c4e762ba75e5efa9baf63e485c514bcd87a33ad1c13fc83f941e4ef0034?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a10a9c4e762ba75e5efa9baf63e485c514bcd87a33ad1c13fc83f941e4ef0034?s=96&d=mm&r=g","caption":"Fetun Delessa"},"url":"https:\/\/www.cosprc.ca\/fr\/author\/rs9ebny670cpwyyn\/"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-23 21:10:25","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/posts\/10538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/comments?post=10538"}],"version-history":[{"count":4,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/posts\/10538\/revisions"}],"predecessor-version":[{"id":20035,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/posts\/10538\/revisions\/20035"}],"wp:attachment":[{"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/media?parent=10538"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/categories?post=10538"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/post_tag?post=10538"},{"taxonomy":"content_type","embeddable":true,"href":"https:\/\/www.cosprc.ca\/fr\/wp-json\/wp\/v2\/content_type?post=10538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}